EDGAR filings

Every filing EDGAR's full-index lists, from every filer: companies, insiders, funds and filing agents. A search that names no form type, ticker or filer CIK covers at most 31 days and defaults to the last 7.

EDGAR holds what was filed electronically. Electronic filing began in 1993 (the earliest filing here is of 1993-02-11) and was phased in filer by filer until May 1996: filings made on paper before 1993, and during the phase-in by a filer not yet on EDGAR, are not on EDGAR and therefore not here.

Form types Filers
Clear

50 rows on this page.

Filed Form Filer Category 8-K items / description Accession
2026-11-12 6-K PRQR
ProQR Therapeutics N.V.
CIK 1612940
Current reports FORM 6-K 0001104659-26-125900
2026-11-12 6-K PRQR
ProQR Therapeutics N.V.
CIK 1612940
Current reports 6-K 0001104659-26-125795
2026-10-30 6-K/A PRQR
ProQR Therapeutics N.V.
CIK 1612940
Current reports FORM 6-K/A 0001104659-26-120645
2026-10-28 6-K PRQR
ProQR Therapeutics N.V.
CIK 1612940
Current reports FORM 6-K 0001104659-26-119371
2026-09-23 6-K PRQR
ProQR Therapeutics N.V.
CIK 1612940
Current reports FORM 6-K 0001104659-26-109819
2026-09-09 6-K PRQR
ProQR Therapeutics N.V.
CIK 1612940
Current reports FORM 6-K 0001104659-26-106138
2026-08-13 6-K PRQR
ProQR Therapeutics N.V.
CIK 1612940
Current reports 6-K 0001104659-26-095425
2026-08-13 6-K PRQR
ProQR Therapeutics N.V.
CIK 1612940
Current reports FORM 6-K 0001104659-26-095422
2026-08-03 4 PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0001104659-26-089780
2026-07-29 SCHEDULE 13G PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0001716774-26-000021
2026-07-29 SCHEDULE 13D/A PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0001104659-26-088126
2026-07-24 SCHEDULE 13G/A PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0000059478-26-000071
2026-07-21 4 PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0001104659-26-085234
2026-07-15 EFFECT PRQR
ProQR Therapeutics N.V.
CIK 1612940
Registrations and prospectuses 9999999995-26-002315
2026-07-15 424B5 PRQR
ProQR Therapeutics N.V.
CIK 1612940
Registrations and prospectuses 0001104659-26-083906
2026-07-15 SCHEDULE 13G/A PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0001104659-26-083818
2026-07-13 4 PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0001104659-26-082890
2026-07-08 4 PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0001104659-26-081762
2026-07-06 F-3 PRQR
ProQR Therapeutics N.V.
CIK 1612940
Registrations and prospectuses 0001104659-26-080750
2026-06-30 SCHEDULE 13D/A PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0001104659-26-079415
2026-06-30 4/A PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0001104659-26-079319
2026-06-30 4 PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0001104659-26-079316
2026-06-26 6-K PRQR
ProQR Therapeutics N.V.
CIK 1612940
Current reports FORM 6-K 0001104659-26-077892
2026-06-26 424B5 PRQR
ProQR Therapeutics N.V.
CIK 1612940
Registrations and prospectuses 0001104659-26-077891
2026-06-25 6-K PRQR
ProQR Therapeutics N.V.
CIK 1612940
Current reports FORM 6-K 0001104659-26-077506
2026-06-03 SCHEDULE 13D/A PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0001104659-26-070195
2026-06-03 4 PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0001104659-26-070090
2026-06-02 6-K PRQR
ProQR Therapeutics N.V.
CIK 1612940
Current reports FORM 6-K 0001104659-26-069450
2026-06-02 3 PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0001104659-26-069449
2026-05-12 6-K PRQR
ProQR Therapeutics N.V.
CIK 1612940
Current reports 6-K 0001104659-26-058981
2026-05-12 6-K PRQR
ProQR Therapeutics N.V.
CIK 1612940
Current reports FORM 6-K 0001104659-26-058980
2026-05-04 6-K PRQR
ProQR Therapeutics N.V.
CIK 1612940
Current reports FORM 6-K 0001104659-26-054484
2026-04-30 6-K PRQR
ProQR Therapeutics N.V.
CIK 1612940
Current reports FORM 6-K 0001104659-26-052201
2026-04-08 6-K PRQR
ProQR Therapeutics N.V.
CIK 1612940
Current reports FORM 6-K 0001104659-26-040893
2026-04-08 6-K PRQR
ProQR Therapeutics N.V.
CIK 1612940
Current reports FORM 6-K 0001104659-26-040682
2026-03-25 6-K PRQR
ProQR Therapeutics N.V.
CIK 1612940
Current reports FORM 6-K 0001104659-26-034158
2026-03-18 3 PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0001104659-26-030893
2026-03-18 3 PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0001104659-26-030887
2026-03-18 3 PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0001104659-26-030885
2026-03-18 3 PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0001104659-26-030870
2026-03-18 3 PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0001104659-26-030867
2026-03-18 3 PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0001104659-26-030865
2026-03-18 3 PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0001104659-26-030862
2026-03-18 3 PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0001104659-26-030858
2026-03-18 3 PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0001104659-26-030855
2026-03-18 3 PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0001104659-26-030830
2026-03-12 20-F PRQR
ProQR Therapeutics N.V.
CIK 1612940
Financial reports 20-F 0001104659-26-026713
2026-03-12 6-K PRQR
ProQR Therapeutics N.V.
CIK 1612940
Current reports FORM 6-K 0001104659-26-026699
2026-02-09 6-K PRQR
ProQR Therapeutics N.V.
CIK 1612940
Current reports FORM 6-K 0001104659-26-011769
2026-02-06 SCHEDULE 13D/A PRQR
ProQR Therapeutics N.V.
CIK 1612940
Ownership 0001104659-26-011489